Delivery Order SPE2DR25D3104-SPE2DR26FE9MN
- Not listed
- The Defense Logistics Agency awarded a $9,963.87 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.63 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for M-M-R II vaccine vials, with a completion deadline of January 28, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,766.37 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial...
- The Defense Logistics Agency awarded a $3,177.90 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,532.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for M-M-R II vaccine vials. This is a non-set-aside competitive award with an ultimate completion date of January 28, 2026. The contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This prime...
- The Defense Logistics Agency awarded a delivery order valued at $6,547.90 to Amerisourcebergen Drug Corp for M-M-R II vaccine vials on February 3, 2026, with an ultimate completion date of February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate office. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 15, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for the awardee. This delivery order represents a task order issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for M-M-R II vaccine vials valued at $15,511.96 with a firm fixed price contract type. The order is scheduled for completion by December 11, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9MNDelivery Order
The Defense Logistics Agency awarded a $9,196.15 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on February 4, 2026, for M-M-R II vaccine vials, with a completion date of February 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of pharmaceutical products and medical supplies to military healthcare programs worldwide. This delivery order for M-M-R II vaccine vials supports the Defense Health Agency's medical supply needs through the DLA Medical Supply Chain. Amerisourcebergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, routinely fulfills such vaccine and pharmaceutical orders under its prime indefinite delivery contract, demonstrating its established capability to meet federal healthcare requirements through open competition. The rapid completion timeline reflects the expedited nature of this vaccine procurement for military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 2/3/26 |